SALUS, Ljubljana, d. d. (LJSE:SALR)

Slovenia · Delayed Price · Currency is EUR

68.50

-1.00 (-1.44%)

At close: Oct 12, 2026

Market Cap	563.02M +33.0%
Revenue (ttm)	758.16M +14.1%
Net Income	18.57M +29.3%
EPS	2.26 +29.5%
Shares Out	8.22M
PE Ratio	30.31
Forward PE	n/a
Dividend	1.20 (1.75%)
Ex-Dividend Date	Apr 28, 2026

Volume	7,690
Open	67.50
Previous Close	69.50
Day's Range	66.50 - 68.50
52-Week Range	46.00 - 72.50
Beta	0.47
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 5, 2026

About SALUS, Ljubljana, d. d.

SALUS, Ljubljana, d. d. engages in the distribution, promotion, sales services, and value-added services for medicinal products or medical devices in Slovenia and internationally. The company offers commercial partnerships to pharmaceutical, biotechnology, consumer healthcare, and medical device companies; and medicinal products, medical devices, sanitary products, dietary supplements, cosmetics, pharmaceutical packaging, and other products to pharmacies, hospitals, community health centers, residential homes for the elderly, veterinary institu... [Read more]

Industry Drugs, Drug Proprietaries, and Druggists' Sundries

Founded 1969

Employees 723

Stock Exchange Ljubljana Stock Exchange

Ticker Symbol SALR

Full Company Profile

Financial Performance

In 2025, SALUS, Ljubljana, d. d.'s revenue was 696.19 million, an increase of 7.30% compared to the previous year's 648.83 million. Earnings were 16.68 million, an increase of 29.78%.

Financial Statements